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MinireviewMore Than One Way
to Skin a Catenin
2000). The various defects leading to stabilized -cat-
enin reside in molecules considered to be components
of the Wnt signaling pathway. Prominent among these
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is Wnt-1 itself, which promotes tumorigenesis when ec-1 DNA Way
topically expressed in the murine mammary gland. AsSouth San Francisco, California 94080
a secreted ligand, Wnt activates frizzled, a cell surface
receptor that engages the intracellular protein dishev-
eled that in turn interferes with glycogen synthase kinaseThe targeted destruction of proteins is a highly con-
3 (GSK3). This is the serine/threonine kinase thatserved process employed by cells to regulate a number
phosphorylates those all-important residues in the regu-of vital functions (Tyers and Willems, 1999). The trans-
latory sequence of -catenin. The kinase does not actport of nutrients, the timing of the cell cycle, gene tran-
alone, but is assembled along with -catenin and APCscription, signal transduction, senescence, and apopto-
on Axin, a cytoplasmic protein containing independentsis are all controlled at some level by the intentional
binding sites for all three of these proteins. The exactdestruction of the proteins regulating these activities. It
relationship of these molecules to each other is unclear,is not surprising then that certain pathological states
but it is thought that APC activates Axin in a manner thatare attributable to defects in the molecules responsible
facilitates the phosphorylation of -catenin by GSK3.for the recognition and destruction of specified targets.
Mutations that render APC incapable of binding Axin areFor example, inactivation of the von Hipple-Lindau tu-
a hallmark of sporadic and heritable forms of colorectalmor suppressor VHL, which is a component of an E3
cancer. Moreover, mutations in Axin that render the pro-ubiquitin ligase, promotes angiogenesis because the
tein incapable of binding to -catenin have been identi-
VHL target HIF evades destruction. Alternatively, the
fied in human hepatocellular cancers.
target protein itself can carry mutations that prevent its
The perilous behavior of stabilized -catenin is largely
recognition by an E3 ligase. This is the case for the proto-
attributable to the inappropriate activation of genes re-
oncogene -catenin, which requires phosphorylation at
sponsive to the TCF/LEF family of transcription factors
specific serine and threonine residues in order to be
(Barker et al., 2000). -catenin binds directly to the TCF/
identified by its destroyer (Polakis, 2000). Mutations af- LEF proteins and activates genes such as cyclin D and
fecting these serine and threonine residues result in c-myc, whose promoters contain binding sites for these
oncogenic forms of -catenin that have been detected transcription factors. By default, -catenin normally un-
in a wide variety of human cancers. The current model dergoes phosphorylation, associates with -TrCP and
maintains that the unphosphorylated mutant forms of is dragged into the proteosomal trashcan, thus avoiding
-catenin elude the F box protein -TrCP, which consti- any encounters with growth controlling genes. Cancer
tutes one component of the E3 ubiquitin ligase charged and development represent two states under which the
with destroying -catenin. However, two new studies default destruction pathway is circumvented and signal-
by Matsuzawa and Reed (2001) and Liu et al. (2001), in ing by -catenin is consummated by gene activation. In
the May issue of Molecular Cell, propose that -TrCP is the healthy adult, though, we do not have a very com-
not the only F box protein capable of fingering -cat- plete picture of where and when -catenin signaling
enin. The papers show that the F box protein Ebi also contributes to normal cellular processes. Perhaps it par-
binds -catenin as part of an E3 ubiquitin ligase that is ticipates in regulating cell division, as suggested by re-
ultimately linked to Siah-1, the product of a p53 inducible cent work describing fluctuations in the levels of -cat-
growth arrest gene. Remarkably, destruction of -cat- enin during the cell cycle (Orford et al., 1999). After all,
enin by this new pathway is not dependent upon its the timely surgical destruction of proteins targeted by E3
phosphorylation. ubiquitin ligases is a key feature of cell cycle progression
-Catenin the Oncogene (Tyers and Willems, 1999). Errors that occur in mitosis
Originally defined as a cell adhesion molecule, -catenin can abruptly halt progression by engaging checkpoints
has gained considerable notoriety as a card-carrying that ultimately impact upon the degradation of cell cycle
oncogene. A potential role for -catenin in cancer was components. The new studies by Matsuzawa and Reed
initially inferred from its association with the tumor sup- and Liu et al. are particularly relevant with respect to
pressor protein adenomatous polyposis coli (APC). cell cycle control in that they have linked the activation
Subsequent work showed that expression of APC de- of the p53 tumor suppressor to the degradation of
creased the stability of -catenin while the Wnt-1 proto- -catenin. The authors also propose a role for this new
oncogene had the opposing effect. Finally, mutations in degradation pathway in cancer, where selection against
wild-type p53 function runs rampant.the -catenin gene, that increased the half-life of the
Siah-1 the Destroyerprotein, were identified in human cancers (Peifer, 1997).
Matsuzawa and Reed linked p53 to -catenin turnoverIt is now evident that the half-life of -catenin can be
using a connect-the-proteins approach starting withextended by a variety of independent genetic defects,
Siah-1, the homolog of the Drosophila seven in absentiaall of which result in cellular transformation (Polakis,
gene sina. The seven refers to the differentiation of the
Drosophila R7 photoreceptor that serves as a read-out
for the genetic analysis of the ras pathway. Expression1 Correspondence: ppolakis@gene.com
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Figure 1. Protein-Protein Interactions in the
Ebi (upper) and -TrCP (lower) Complexes
“N” indicates N terminus, “F” indicates F box,
“PPP” represents phosphorylation of -cat-
enin, “E2” indicates a ubiquitin conjugating
enzyme, and “MCR” is the mutation cluster
region.
of Sina is essential to R7 development in that it orches- regulation of -catenin by Siah-1 further implicated Ebi
in the pathway. Finally, the direct binding of Ebi to antrates the destruction of Tramtrack, a transcriptional
corepressor inhibitory to ras signaling (Tang et al., 1997). amino-terminal fragment of -catenin positioned Ebi as
the foot soldier in the chain of command leading fromSubsequently, it was shown that Siah-1 destroys mam-
malian proteins, in particular, the netrin receptor DCC, Siah-1 to the destruction of -catenin (Figure 1).
So where does the APC tumor suppressor protein fitto which it also binds (Hu et al., 1997). The Reed lab
ran a yeast two-hybrid screen with Siah-1 and netted a into all of this? Liu et al. verified the interaction between
Siah-1 and APC in mammalian cells and demonstratedSiah-1 interacting protein aptly referred to as SIP. Local
sequence identity was noted between SIP and Sgt1, a direct binding in vitro between a C-terminal fragment of
APC and Siah-1. Liu et al. also extended the findingprotein known to associate with the Skp1 component
of an SCF (Skp1, cullin, F box) E3 ubiquitin ligase. Ac- that Siah-1 could downregulate -catenin in mammalian
cells to a biological setting by showing that Siah-1 over-cordingly, Skp1 clones were captured in a yeast two-
hybrid screen in which SIP was employed as bait. More- expression partially interfered with the dorsalization of
Xenopus embryos. Dorsal axis induction in Xenopus isover, three-hybrid assays showed that SIP could bridge
the connection from Skp1 to Siah-1, which was already commonly employed as a read-out for Wnt signaling
and also occurs in response to the overexpression ofknown to associate with the ubiquitin conjugating en-
zyme Ubc-H5. -catenin. Siah-1 was unable to downregulate -catenin
in cancer cells lacking wild-type APC, leading Liu et al.The SIP protein thus represented a missing link, po-
tentially connecting Siah-1 to a Skp1 complex. The story to propose that Siah-1 was dependent upon APC for
this function. Furthermore, in cells containing wild-typetook an unexpected turn, however, when a C-terminal
fragment of the APC tumor suppressor was also picked APC, overexpression of a C-terminal fragment of APC
inhibited the downregulation of -catenin observed onup in the Siah-1 yeast two-hybrid screen—a finding elab-
orated upon in the paper by Liu et al. This prompted overexpression of Siah-1. The same C-terminal frag-
ment of APC also enhanced the transcriptional activityboth groups to test the effects of Siah-1 on the regulation
of -catenin. Overexpression of Siah-1 downregulated of -catenin in the absence of Siah-1 overexpression.
Two Paths to Destruction-catenin protein and transcriptional activity while non-
functional derivatives of Siah-1 interfered with wild-type It seems quite apparent from the bulk of the work pre-
sented in the two papers that Siah-1 impacts uponSiah-1 in these assays. What remained was to connect
Siah-1 to an E3 component that would directly recognize -catenin signaling. Is this new pathway for the destruc-
tion of -catenin independent of that which has been pre--catenin. A likely suspect was -TrCP, but this F box
protein failed to coimmunoprecipitate with Siah-1, de- viously described? Not entirely, because both pathways
are dependent upon the APC tumor suppressor. A keyspite the presence of Skp1 in the Siah-1 immune com-
plex. Enter Ebi, an F box protein that was linked to distinction, though, is that the two pathways utilize dif-
ferent F box proteins for the recognition of the substrateSina and the destruction of Tramtrack through genetic
analysis of the R7 phenotype in flies (Dong et al., 1999). -catenin. This latter point raises an important issue in
that the F box protein Ebi, unlike -TrCP, does not re-Indeed, when Ebi was coexpressed with Siah-1, SIP,
and Skp1, the whole crew was fished out of the cell quire phosphorylation of the -catenin amino terminal
regulatory sequence for recognition. The implication,lysates upon recovery of Ebi by immunoprecipitation.
By contrast,-TrCP netted only Skp1 when tested under which is supported by both papers, is that the Siah-1
system has the capacity to destroy oncogenic forms ofthe same conditions. The demonstration that a deletion
mutant of Ebi lacking the F box interfered with the down- -catenin, which escape recognition by -TrCP. One
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might wonder how Wnt signaling, which operates by system is engaged by p53? It might be one reason, but
it is already clear that Siah-1 promotes the destructiondisrupting the phosphorylation of -catenin, could func-
tion in the face of an Ebi destruction system that disre- of molecules other than -catenin and any given F box
protein likely handles multiple substrates. Could thegards the phosphorylation signal altogether. The answer
may be that Siah-1 does not function constitutively in elimination of -catenin alone halt cell division? This is
not known. Mouse embryos null for -catenin developcells, but rather is recruited into action by genotoxic
stress signals. In particular, the activation of p53, a.k.a. normally to day 6.5 p.c., but the persistence of maternal
-catenin could account for this. At minimum, the de-the guardian of the genome, has been shown to promote
the expression of Siah-1 (Amson et al., 1996). Indeed, struction of -catenin can be considered as one facet
in the panoply of emergency alerts triggered by p53.the papers by Matsuzawa and Reed and Liu et al. show
that the overexpression of wild-type p53 induces the A second issue is whether -catenin degradation is a
specific effector of p53. Is the downregulation of -cat-downregulation of -catenin through a mechanism in-
hibited by the overexpression of dominant negative enin by Ebi simply a secondary consequence of cell
cycle arrest? The Reed lab thinks not, because growthSiah-1. Dominant negative versions of SIP, Ebi, and the
C-terminal fragment of APC also inhibited the downreg- arrest incurred by the treatment of cells with thymidine
or nocodazole did not alter -catenin levels. However,ulation of -catenin by p53.
The new findings suggest a model in which indepen- Liu et al. found that the expression of the cell cycle
inhibitor p21 also downregulated -catenin. This is con-dent signals impinge upon the regulation of -catenin
by engaging distinct machines that share some common sistent with a previous genetic screen in Drosophila
where mutations in Ebi rescued phenotypes resultingcomponents (Figure 1). Both systems utilize Skp1, APC,
and an F box protein that recognizes N-terminal se- from the expression of p21 (Boulton et al., 2000). More-
over, previous work has shown that p21 induces Siah-1quence in -catenin. However, as demonstrated by the
Reed lab, as well as by others (Soel et al., 2001), Skp1 expression (Roperch et al., 1999).
Siah-1 and Cancerappears to interact with different partners depending
upon which F box protein is associated with it. Both Ebi Finally, what are the implications for the Siah-1/Ebi sys-
tem in colorectal cancer? A few questions might beand -TrCP bind to the C-terminal F box binding domain
of Skp1, but SIP binds Skp1 only when Skp1 is associ- addressed by reexamining existing data. At first glance,
one might conclude that the loss of APC would crippleated with Ebi. Does Ebi train Skp1 to select its partners?
This might relate to the physical structure of Skp1 in the -TrCP system and subsequent selection against
p53 activity would then finish off the cell’s options forcomplex with the Skp2 F box protein. The complex con-
tains a core structure with sequence common to all Skp1 regulating -catenin. However, the vast majority of mu-
tations in APC truncate the protein at or N-terminal toand F box proteins, but also reveals a second, variable
interface, that predicts unique interactions specified by the mutation cluster region (MCR), thus abrogating Axin
and Siah-1 binding in one fell swoop. These APC muta-different F box proteins (Schulman et al., 2000). A second
mystery concerns the interaction of APC and SIP with tions should effectively eliminate both modes of regulat-
ing -catenin, thereby relieving subsequent selectivethe same 105-C-terminal amino acid sequence in Siah-1.
Are these interactions mutually compatible or exclusive? pressure against wild-type p53. However, this is not the
case as mutations in p53 and APC coexist in humanThis issue was not addressed in the papers, but resolv-
ing it could certainly change the way in which the model colorectal cancers. This suggests that the dysregulation
of -catenin is not a principal driving force for the selec-is viewed. Also, Ebi and -TrCP bind to the same amino-
terminal 90-amino acid sequence in -catenin. Do the tion against p53 in tumor progression. Is it even a con-
tributing force? This might be evaluated by looking atpathways converge or compete at the level of substrate?
Will the Wnt-1 signal fail to stabilize -catenin in the the genetics of a special subset of cancers with defects
in -catenin signaling. This subset includes tumors thatcontext of genotoxic stress?
What are the biological ramifications of having two have retained wild-type APC, but have acquired onco-
genic mutations in -catenin or inactivating mutationsindependent systems designed to regulate -catenin?
The Wnt-1 signal is handily employed during develop- in the tumor suppressor Axin. These mutations would
compromise the tumor cell’s ability to regulate-cateninment but evidence is sparse for its involvement in regu-
lating normal cells in adult tissues. The levels of -ca- by -TrCP, while leaving the Siah-1/Ebi system intact.
Therefore, one might anticipate stronger or earlier selec-tenin have been shown to fluctuate with the cell cycle
and its forced expression disproportionately drives cells tion against p53 during the progression of these cancers
relative to those with mutant APC. Alternatively, it isinto S phase and also inhibits their arrest by -irradiation
(Orford et al., 1999). Therefore, a signal emanating from conceivable that mutations in APC, particularly those
affecting the Siah-1 binding site, might coexist in tumorsa source other than a Wnt ligand might have a place in
regulating -catenin during the cell cycle and upon its containing mutations in either -catenin or Axin. A sub-
stantial number of oncogenic mutations in -catenindisruption by stress. Accordingly, growth arrest by p53
expression, as well as by genotoxic insults, drove down have been reported, but none in cancers that are also
mutant for APC (Polakis, 2000). There is an additional-catenin levels in a Siah-1-dependent manner (Matsu-
zawa and Reed, 2001; Liu et al., 2001). One view of this twist here in that some cancers contain mutations that
delete extensive amino-terminal sequence from -cat-model is that the -TrCP-based system is by default
capable of preventing runaway accumulation of -cat- enin (Iwao et al., 1998). As both Ebi and -TrCP bind to
the amino-terminal region of -catenin, these deletionenin, but a second system employing Ebi is required to
fully shut it down in the event of an emergency. Is the mutants should be bulletproof to destruction by either
system. It would be of interest to know if these cancerselimination of -catenin the reason why the Siah-1/Ebi
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are any more aggressive than their counterparts con-
taining point mutations in the -catenin gene.
Intentionally destroying a protein just to turn off its
activity seems like a barbaric and costly practice. It is
equivalent to shooting out the lights when the flip of
a switch would suffice. Perhaps targeted degradation
offers the certainty of an irreversible event that less
dramatic forms of posttranslational modification cannot.
Whatever the reason, cells have obviously maintained
and expanded the use of this blunt instrument. The new
work by Matsuzawa and Reed and Liu et al. tells us that
a single substrate such as -catenin can be the victim
of at least two different reapers. In this regard, the cell
appears to exert Herculean efforts to ensure that -cat-
enin does not speak unless spoken to and is promptly
evicted in the event an emergency. It must be worth the
effort.
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